In addition, self-reported sleep quality scores improved by 72% in those treated with ashwagandha extract, but only 29% in those given placebo
Abstract Background Cardiovascular disease is a leading cause of post-transplant mortality in kidney transplant recipients (KTRs), especially those with diabetes
Last Published 05.01.2026 Effective Date: 01.01.2026 This policy addresses the use of interspinous bony fusion devices and interspinous decompression systems
Beyond its primary indication in sleep, DSIP offers a cascade of secondary benefits, including stress reduction, pain relief, neuroprotection, and support in addiction recovery ( 4, 5, 6, 7 )
Mental health should never come second to a physical transformation